Better Therapeutics, Inc. Quarterly Selling and Marketing Expense in USD from Q1 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Better Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2021 to Q3 2023.
  • Better Therapeutics, Inc. Selling and Marketing Expense for the quarter ending September 30, 2023 was $1.39M, a 10.6% decline year-over-year.
  • Better Therapeutics, Inc. Selling and Marketing Expense for the twelve months ending September 30, 2023 was $6.9M, a 6.72% increase year-over-year.
  • Better Therapeutics, Inc. annual Selling and Marketing Expense for 2022 was $6.98M, a 199% increase from 2021.
  • Better Therapeutics, Inc. annual Selling and Marketing Expense for 2021 was $2.34M, a 981% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $6.9M $1.39M -$165K -10.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.06M $1.7M +$21K +1.25% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $7.04M $2.1M +$60K +2.94% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $6.98M $1.7M +$518K +44% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $6.46M $1.56M +$1.01M +182% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.46M $1.68M +$1.12M +198% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.34M $2.04M +$2M +4653% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.34M $1.18M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $552K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $564K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $43K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.